HK1214498A1 - 药物监测与调控系统和方法 - Google Patents

药物监测与调控系统和方法 Download PDF

Info

Publication number
HK1214498A1
HK1214498A1 HK16102367.3A HK16102367A HK1214498A1 HK 1214498 A1 HK1214498 A1 HK 1214498A1 HK 16102367 A HK16102367 A HK 16102367A HK 1214498 A1 HK1214498 A1 HK 1214498A1
Authority
HK
Hong Kong
Prior art keywords
subject
concentration
drug
dose
pharmaceutical composition
Prior art date
Application number
HK16102367.3A
Other languages
English (en)
Chinese (zh)
Inventor
‧霍姆斯
E‧霍姆斯
Original Assignee
Labrador Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labrador Diagnostics Llc filed Critical Labrador Diagnostics Llc
Publication of HK1214498A1 publication Critical patent/HK1214498A1/zh

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK16102367.3A 2012-10-23 2013-10-22 药物监测与调控系统和方法 HK1214498A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261717609P 2012-10-23 2012-10-23
US61/717,609 2012-10-23
PCT/US2013/066238 WO2014066428A1 (en) 2012-10-23 2013-10-22 Drug monitoring and regulation systems and methods

Publications (1)

Publication Number Publication Date
HK1214498A1 true HK1214498A1 (zh) 2016-07-29

Family

ID=50486139

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102367.3A HK1214498A1 (zh) 2012-10-23 2013-10-22 药物监测与调控系统和方法

Country Status (9)

Country Link
US (2) US20140114676A1 (https=)
EP (1) EP2911642B1 (https=)
KR (1) KR20150079660A (https=)
CN (1) CN104884029A (https=)
AU (2) AU2013334700A1 (https=)
CA (1) CA2887669A1 (https=)
HK (1) HK1214498A1 (https=)
IN (1) IN2015DN03826A (https=)
WO (1) WO2014066428A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10083400B2 (en) 2012-10-05 2018-09-25 Diane R. MOULD System and method for providing patient-specific dosing as a function of mathematical models updated to account for an observed patient response
US10777313B2 (en) 2013-06-13 2020-09-15 Carefusion 303, Inc. Analytics regarding ventilated patients
US11183287B2 (en) * 2013-06-13 2021-11-23 Carefusion 303, Inc. Analytics regarding patient care
US12027243B2 (en) 2017-02-17 2024-07-02 Hc1 Insights, Inc. System and method for determining healthcare relationships
US20210005324A1 (en) * 2018-08-08 2021-01-07 Hc1.Com Inc. Methods and systems for a health monitoring command center and workforce advisor
WO2016115492A1 (en) * 2015-01-16 2016-07-21 Ameritox, Ltd. Normalizing measured drug concentrations in oral fluids and testing for potential non-compliance with drug treatment regimen
AU2016245862A1 (en) * 2015-04-09 2018-02-22 Diane R. Mould Systems and methods for patient-specific dosing
KR102415992B1 (ko) 2016-04-15 2022-07-04 다케다 야쿠힌 고교 가부시키가이샤 약물동역학 약물 투약 요법을 제공하는 방법 및 장치
US10896749B2 (en) * 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
CN109718112B (zh) * 2017-10-30 2020-12-29 京东方科技集团股份有限公司 用药提醒方法、装置及计算机可读存储介质
JP2021518603A (ja) * 2018-03-20 2021-08-02 シートムエックス セラピューティクス，インコーポレイテッド 哺乳動物対象における活性化可能抗体種の定量薬理学モデリングのためのシステムおよび方法
CN108334116A (zh) * 2018-04-23 2018-07-27 上海健康医学院 一种动态可控的微剂量药液精准输送系统及方法
BR112020024917A2 (pt) * 2018-06-06 2021-03-09 Minoryx Therapeutics S.L. Método de administrar uma quantidade terapeuticamente eficaz de 5-[[4-[2-[5-(1-hidroxietil)piridin-2-il]etoxi]fenil]metil]-1,3-tiazolidina-2,4-diona
EP3803340A1 (en) 2018-06-07 2021-04-14 Pharmacolog i Uppsala AB Method and system for evaluation of drug concentration in blood, plasma or serum
PT3870957T (pt) * 2018-10-23 2025-09-01 Amgen Inc Calibração automática e manutenção automática de modelos espetroscópicos para previsões em tempo real
CA3124675A1 (en) * 2018-12-21 2020-06-25 Thsee, Llc Method for optimization of cannabis dosage and mixture of active cannabinoids
WO2021097653A1 (en) * 2019-11-19 2021-05-27 National University Of Singapore Optimisation of combination drug therapies
US20210304846A1 (en) * 2020-03-29 2021-09-30 Stephen J. Brown Personalized compounding of therapeutic components and tracking of their influence on a measured parameter using a complex interaction model
CN111489822A (zh) * 2020-04-02 2020-08-04 首都医科大学附属北京安定医院 一种治疗药物监测结果解释系统
CN111870770A (zh) * 2020-08-31 2020-11-03 上海应用技术大学 一种智能远程输液泵控制监测系统
KR102481888B1 (ko) 2020-09-01 2022-12-28 고려대학교 산학협력단 딥러닝을 이용한 수면유도제 투여량 예측방법 및 예측 장치
CN113823365A (zh) * 2021-09-30 2021-12-21 北京兴德通医药科技股份有限公司 临床研究质量控制方法、系统、电子设备和存储介质
KR102840320B1 (ko) 2023-02-13 2025-08-01 주식회사 지오비전 공동 다층 퍼셉트론 모델을 이용한 약제 농도 모니터링 시스템
WO2025006459A1 (en) * 2023-06-29 2025-01-02 Prxcision, Inc. Machine learning for real-time decision support
KR20250028730A (ko) * 2023-08-22 2025-03-04 충북대학교 산학협력단 혈중 농도 변화 모사를 위한 약물 평가 방법 및 약물 평가 시스템
WO2025059764A1 (en) * 2023-09-18 2025-03-27 Appmed Inc. System and method for monitoring and identifying posology efficacy for an individual
CN120674104B (zh) * 2025-06-18 2026-03-03 首都医科大学附属北京世纪坛医院 一种用于药物试验研究室受试者体征动态监控系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747002B2 (en) * 1999-05-11 2004-06-08 Ortho-Mcneil Pharmaceutical, Inc. Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
US7124031B1 (en) * 2000-05-11 2006-10-17 Medco Health Solutions, Inc. System for monitoring regulation of pharmaceuticals from data structure of medical and labortory records
US6599281B1 (en) * 2000-05-03 2003-07-29 Aspect Medical Systems, Inc. System and method for adaptive drug delivery
US7860583B2 (en) * 2004-08-25 2010-12-28 Carefusion 303, Inc. System and method for dynamically adjusting patient therapy
US20040014097A1 (en) * 2002-05-06 2004-01-22 Mcglennen Ronald C. Genetic test apparatus and method
US7585680B2 (en) * 2003-08-28 2009-09-08 Marshfield Medical Research And Education Foundation Method and device for monitoring medication usage
GB0420256D0 (en) * 2004-09-13 2004-10-13 Cassells John M Method and apparatus for sampling and analysis of fluids
KR101931899B1 (ko) 2005-05-09 2018-12-21 테라노스, 인코포레이티드 현장진료 유체 시스템 및 그 용도
US20060283465A1 (en) * 2005-06-16 2006-12-21 Nickel Janice H Smart drug delivery system and a method of implementation thereof
EP3703058A1 (en) * 2005-11-29 2020-09-02 Children's Hospital Medical Center A method of selecting a medication for a patient
KR100867324B1 (ko) * 2007-03-13 2008-11-06 가톨릭대학교 산학협력단 혈중약물농도측정 처방 자동화 방법
US20080262867A1 (en) * 2007-04-18 2008-10-23 Janus Health, Inc. Patient management system and method
CN100580448C (zh) * 2007-08-10 2010-01-13 复旦大学附属华山医院 一种测定人血浆中苯妥英及其前体药物和代谢物的方法
ES2447875T3 (es) 2007-10-02 2014-03-13 Theranos, Inc. Dispositivos modulares para punto de cuidados y usos de los mismos
EP2286359A2 (en) * 2008-03-27 2011-02-23 Medtronic, Inc. Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools
CN102395310A (zh) * 2009-02-26 2012-03-28 莫尔研究应用有限公司 用于自动监控糖尿病相关治疗的方法以及系统
KR20140040290A (ko) * 2009-07-22 2014-04-02 일라이 릴리 앤드 캄파니 제약 요법과 관련된 체중 증가를 예측하기 위한 방법
US20120203573A1 (en) * 2010-09-22 2012-08-09 I.D. Therapeutics Llc Methods, systems, and apparatus for optimizing effects of treatment with medication using medication compliance patterns

Also Published As

Publication number Publication date
EP2911642A1 (en) 2015-09-02
CA2887669A1 (en) 2014-05-01
WO2014066428A1 (en) 2014-05-01
US20140114676A1 (en) 2014-04-24
US20160342768A1 (en) 2016-11-24
CN104884029A (zh) 2015-09-02
AU2018204120A1 (en) 2018-06-28
EP2911642B1 (en) 2022-11-16
KR20150079660A (ko) 2015-07-08
EP2911642A4 (en) 2016-06-08
AU2013334700A1 (en) 2015-04-30
IN2015DN03826A (https=) 2015-10-02

Similar Documents

Publication Publication Date Title
EP2911642B1 (en) Drug monitoring and regulation systems and methods
US20250342928A1 (en) Systems and methods for patient-specific dosing
US20240371491A1 (en) Systems and methods for drug-agnostic patient-specific dosing regimens
Hasanzad et al. Artificial intelligence perspective in the future of endocrine diseases
CN102822834A (zh) 用于预测治疗结果的基于计算机的系统
US8538778B2 (en) Methods and systems for integrated health systems
EP2223248A1 (en) Simulating patient-specific outcomes
EP4107759A1 (en) Devices, systems, and methods for predicting blood glucose levels based on a personalized blood glucose regulation model
WO2020185699A1 (en) Systems and methods for drug-agnostic patient-specific dosing regimens
CN117296102A (zh) 重症肌无力患者他克莫司治疗剂量精准选择的系统及应用
AU2018258683A1 (en) System and method for predicting survival time
CN106999041A (zh) 用于健康相关问题的管理的智能记录
RU2686048C2 (ru) Способ и устройство для определения уровня глюкозы в физиологической жидкости пациента и компьютерный программный продукт
CN113782196A (zh) 健康管理方法、装置和系统
EP4113535A1 (en) Remote monitoring methods and systems for monitoring patients suffering from chronical inflammatory diseases
CN120380484A (zh) 确定针对决策支持模型的用户特定超参数
US20210407649A1 (en) Therapy platform and method of use
EP4348662A1 (en) Systems and methods for monoclonal antibody nomograms
US20200312429A1 (en) Personalized contextualization of patient trajectory
EP4700794A1 (en) Real-time delivery of dynamic, personalized digital therapies to users for addressing obesity conditions using phenotype-driven digital twin models
HK40079892A (en) Systems and methods for patient-specific dosing
Meng et al. Application of Data Science in Management of Type 1 Diabetes
Maaitah Telemedicine Interventions on Clinical Outcomes in Patients: A Systematic Review and Meta-Analysis